drugset
drugset / Trial / NCT01495338

A Comparison of the Safety and Comfort of AC-170

NCT01495338 ↗

Phase 1 Completed 60 enrolled Aciex Therapeutics, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the safety and comfort of AC-170 compared to a placebo.

Timeline

Start
2011-12
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetirizine Other / unclassified 0.17 % Other
Subject Cetirizine Other / unclassified 0.24 % Other
Comparator Olopatadine Other / unclassified 0.2 % Other

Indications

No indication recorded.